A potential new coral disease, currently coined Fast Lesion Progression (FLP), has been observed affecting coral reefs across the Florida Keys. FLP manifests as large, quickly spreading lesions on Orbicella faveolata colonies, often accompanied by sloughy tissue at the lesion line. To investigate this potentially novel disease, we tagged and monitored 51 corals across three Florida Keys reef sites. We reexamined photos from 234 of the first O. faveolata colonies treated at six sites and found that 20.5% of presumed SCTLD-affected O. faveolata were instead FLP- style lesions, with offshore Upper Keys reefs having a higher percentage of historic FLP-affected colonies than other sites. 3% of colonies were affected with both SCTLD and FLP concurrently. We assessed photos of 40 amoxicillin-treated lesions from 2019-2020 and 2022-2023 and found treatment efficacy to be 45%, and an additional 23 from 2022-23 for which efficacy was 17.4%. Finally, we collected 220 samples, including TEM, histology, and microbiome samples, from FLP-affected corals as well as unaffected control corals for further analyses and comparison to previously studied coral diseases by collaborators. FLP has been observed to be a relatively prevalent and highly virulent threat to O. faveolata colonies, which are a vital reef building species. We recommend the prioritization and funding of continued work on this topic to determine other aspects of the disease, such as seasonality, as well as potential treatments to stop the progression of lesions.
The content on the Florida Department of Environmental Protection's (DEP's) website was written and published in English, and English is the sole authoritative language for all such content. As an aid to site visitors who might benefit from multiple language options, the website offers an automated translation feature for browser content in the footer. The translation link will not convert attached or linked files, such as PDFs.
The website translation feature uses Gtranslate® (https://www.drupal.org/project/gtranslate). Gtranslate® is a third-party tool which is not owned, maintained, modified, or controlled in any way by DEP, and which is not endorsed by DEP as preferable to either human-generated translations, or any other automated translation options.
Translation is a nuanced and complex activity and computer-generated translations cannot be expected to be perfectly accurate. Automated translations of this site are not reviewed in advance by DEP and could convey incorrect or offensive language. DEP disclaims any liability for errors, omissions, or interpretive inconsistencies arising in the context of such translation. Site users assume all risk in using translated text. DEP is not responsible for any loss, damage, or harm resulting from reliance on translated text. Use of the translation tool in this website implies understanding and agreement with this assumption and disclaimer.